Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
Prostatic Neoplasms
Interventions
DRUG

cetuximab

No verifiable data available, PI relocated

DRUG

docetaxel

No verifiable data available, PI relocated

Trial Locations (1)

77030

Baylor College of Medicine - Methodist Hospital, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

The Methodist Hospital Research Institute

OTHER